Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
12.18
+0.10 (0.83%)
Dec 20, 2024, 4:00 PM EST - Market closed
Intellia Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 1,241 | 2,731 | 2,974 | 8,799 | 3,514 | 717 | |
| Market Cap Growth | -25.40% | -8.18% | -66.20% | 150.41% | 390.02% | 20.99% | |
| Enterprise Value | 397 | 1,856 | 2,223 | 7,727 | 3,128 | 441 | |
| Last Close Price | 12.18 | 30.49 | 34.89 | 118.24 | 54.40 | 14.67 | |
| PS Ratio | 27.14 | 75.27 | 57.06 | 266.22 | 60.59 | 16.64 | |
| PB Ratio | 1.29 | 2.60 | 2.41 | 8.46 | 6.67 | 2.66 | |
| P/TBV Ratio | 2.17 | 2.60 | 2.41 | 8.46 | 6.67 | 2.66 | |
| EV/Sales Ratio | 9.22 | 51.17 | 42.65 | 233.76 | 53.94 | 10.23 | |
| Debt / Equity Ratio | 0.11 | 0.11 | 0.11 | 0.07 | 0.07 | 0.07 | |
| Asset Turnover | 0.04 | 0.03 | 0.04 | 0.03 | 0.11 | 0.13 | |
| Quick Ratio | 6.31 | 8.23 | 9.45 | 5.97 | 9.33 | 7.98 | |
| Current Ratio | 6.73 | 8.67 | 9.61 | 6.11 | 9.59 | 8.12 | |
| Return on Equity (ROE) | -52.23% | -42.10% | -41.67% | -34.18% | -33.69% | -36.34% | |
| Return on Assets (ROA) | -27.81% | -22.83% | -20.35% | -16.99% | -16.89% | -19.51% | |
| Return on Capital (ROIC) | -30.28% | -25.44% | -23.09% | -19.92% | -19.98% | -23.48% | |
| Earnings Yield | -42.10% | -17.62% | -15.95% | -3.04% | -3.82% | -13.88% | |
| FCF Yield | -29.27% | -14.94% | -11.66% | -2.70% | -1.52% | -15.34% | |
| Buyback Yield / Dilution | -11.02% | -15.33% | -8.57% | -26.63% | -18.50% | -9.70% | |
| Total Shareholder Return | -11.02% | -15.33% | -8.57% | -26.63% | -18.50% | -9.70% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.